You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 138 No. 1, January 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology, Other
 •Endocrine Surgery
 •Gastrointestinal/ Upper Foregut
 •Alert me on articles by topic

Adenocarcinoma of the Third and Fourth Portions of the Duodenum

Results of Surgical Treatment

Adriano Tocchi, MD; Gianluca Mazzoni, MD; Francesco Puma, MD; Michelangelo Miccini, MD; Diletta Cassini, MD; Elia Bettelli, MD; Sandro Tagliacozzo, MD

Arch Surg. 2003;138:80-85.

Hypothesis  To verify the adequacy of duodenal segmentectomy after intestinal derotation in the treatment of primary adenocarcinoma of the third and fourth portions of the duodenum.

Design  A retrospective review of the surgical management of patients who underwent derotation of the third and fourth portions of the duodenum was undertaken to determine long-term outcome.

Setting  Departments of surgery in 3 university hospitals.

Patients  Between January 1, 1980, and December 31, 2000, 47 patients with primary adenocarcinoma of the third and fourth portions of the duodenum were surgically treated at 3 different institutions.

Main Outcome Measures  Details of primary surgery were abstracted from clinical records of the original hospital referral. Postoperative clinical course and long-term outcome were evaluated by a review of the hospital records and follow-up.

Results  The results of a barium swallow test series was positive in 38 cases (80.8%) and esophagogastroduodenoscopy was primarily diagnostic in 30 patients (63.8%). In all cases duodenal segmentectomy was attempted. Twenty-two patients underwent palliative gastrojejunal bypass and in 9 patients pancreaticoduodenectomy was performed. In 16 cases duodenal segmentectomy was performed after intestinal derotation. Anastomoses were performed manually in all cases. Fifteen of the resected patients died of recurrent disease. A median (SD) disease-free survival of 36 (23.6) months (range, 6-85 months) was observed. The median (SD) overall survival was 37.5 (23.9) months (range, 11-85 months), the overall 5-year survival rate was 23% (11 patients), and the actuarial 5-year survival rate was 51% (24 patients).

Conclusions  Duodenal segmentectomy associated with intestinal derotation was shown to be a straightforward, safe procedure for the treatment of the primary adenocarcinoma of the third and fourth portions of the duodenum. This surgical procedure should be preferred to pancreaticoduodenectomy because it is associated with negligible rates of morbidity and mortality, while allowing for satisfactory margin clearance and adequate lymphadenectomy.


From the First Department of Surgery of the University of Rome "La Sapienza" Medical School, Rome, Italy (Drs Tocchi, Mazzoni, Miccini, Cassini, Bettelli, and Tagliacozzo); Department of General and Thoracic Surgery of the University of Perugia Medical School, Perugia, Italy (Dr Puma); and the Department of Surgery of the University of Cagliari Medical School, Cagliari, Italy (Dr Tagliacozzo).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma.
Gold et al.
Ann. Surg. Oncol. 2007;14:3159-3167.
ABSTRACT | FULL TEXT  

Editorial: Duodenal Adenocarcinoma: Is Total Lymph Node Sampling Predictive of Outcome?
Gibbs
Ann. Surg. Oncol. 2004;11:354-355.
FULL TEXT  

Segmental Resection of the Third Portion of the Duodenum for a Gastrointestinal Stromal Tumor: a Case Report
Sakamoto et al.
Jpn J Clin Oncol 2003;33:364-366.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.